Music Royalties Inc. (‘MRI’) declares an increase in the monthly dividend to $0.002 per share on its common stock, representing a 33% increase from 1.8 cents to 2.4 cents per year for a 6% yield for investors on the last financing and a 16% yield for original investors.
This dividend increase marks the third significant increase in the dividend (+20%, +50%, +33%) reflecting MRI’s long-term plan of making accretive acquisitions which underpin the ability to grow the dividend by double digit rates on an ongoing basis. The company’s goal is to list publicly to allow music fans as investors to own a share of passive music streaming cash flow from the top global artist brands, in an age where streaming is growing exponentially.
Our Dividend Track Record
MRI has a three year increasing dividend track record and by the end of 2021 will have paid out a total of 4.3 cents in cumulative dividends per share, representing 29% ROI from dividends alone, before capital gains for original investors. To date MRI has paid out 18 dividends totalling $1.75 million.
Our accretive acquisition model means we will only do deals that allow us to continually increase our dividend and stock price. MRI is committed to passing through our streaming revenues in full. We have an extremely small fixed overhead because MRI is a portfolio and is not in the music business. Hence, we are similar to an ETF, but structured as a stock. MRI is not a fund, which focuses on taking a percentage of assets under management as a fee. A fund is focused on increasing their management fee whereas MRI is only focused on increasing the dividend and the stock price.
About Music Royalties Inc.
Music Royalties Inc. is an artist and investor partnership which provides direct exposure to music revenues from the hyper-growth in global streaming platforms by acquiring song royalties for our shareholders. Our goal is to increase share value by accumulating a diversified portfolio of cash flowing royalties in order to pay increasing dividends.
Contact
Connor Gallagher
+1 647-921-2206